Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Women undergoing hysterectomy, myomectomy have similar short-term outcomes

Key clinical point: Hysterectomy and myomectomy resulted in similar treatment benefits in women between 6 weeks and 12 weeks after surgery.

Major finding: Both groups had a significant improvement in overall Uterine Fibroid Score-Quality of Life (UFS-QoL) scores postsurgery (hysterectomy, 31; myomectomy, 30) and in UFS-QoL symptom severity (hysterectomy, 41; myomectomy, 37).

Study details: An analysis of 1,295 women who underwent hysterectomy or myomectomy for treatment of fibroids in the COMPARE-UF study.

Disclosures: COMPARE-UF is funded by the Agency for Healthcare Research and Quality (AHRQ), Patient-Centered Outcomes Research Institute (PCORI), and the National Institutes of Health. Dr. Nicholson reported no relevant conflicts of interest.


Nicholson WK et al. ASRM 2019, Abstract SYT07.